Kiumars Shahrokh, Ph.D. - Publications

Affiliations: 
2012 Pharmacology and Toxicology University of Utah, Salt Lake City, UT 
Area:
Toxicology, General Biophysics, Biochemistry

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Shahrokh K, Cheatham TE, Yost GS. Conformational dynamics of CYP3A4 demonstrate the important role of Arg212 coupled with the opening of ingress, egress and solvent channels to dehydrogenation of 4-hydroxy-tamoxifen. Biochimica Et Biophysica Acta. 1820: 1605-17. PMID 22677141 DOI: 10.1016/J.Bbagen.2012.05.011  0.507
2012 Shahrokh K, Orendt A, Yost GS, Cheatham TE. Quantum mechanically derived AMBER-compatible heme parameters for various states of the cytochrome P450 catalytic cycle. Journal of Computational Chemistry. 33: 119-33. PMID 21997754 DOI: 10.1002/Jcc.21922  0.52
2011 Thomas KC, Ethirajan M, Shahrokh K, Sun H, Lee J, Cheatham TE, Yost GS, Reilly CA. Structure-activity relationship of capsaicin analogs and transient receptor potential vanilloid 1-mediated human lung epithelial cell toxicity. The Journal of Pharmacology and Experimental Therapeutics. 337: 400-10. PMID 21343315 DOI: 10.1124/Jpet.110.178491  0.434
2010 Moore CD, Shahrokh K, Sontum SF, Cheatham TE, Yost GS. Improved cytochrome P450 3A4 molecular models accurately predict the Phe215 requirement for raloxifene dehydrogenation selectivity. Biochemistry. 49: 9011-9. PMID 20812728 DOI: 10.1021/Bi101139Q  0.534
Show low-probability matches.